A comparison of the clinical outcomes of patients with invasive lobular carcinoma and invasive ductal carcinoma of the breast according to molecular subtype in a Korean population

Abstract

Similar to IDC patients, molecular subtype should be considered when determining the prognosis and treatment regimen for ILC patients.